Halozyme Therapeutics
HALO
#2120
Rank
S$9.77 B
Marketcap
$77.16
Share price
-0.44%
Change (1 day)
42.55%
Change (1 year)

Halozyme Therapeutics (HALO) - Cash on Hand

Cash on Hand as of June 2024 : S$0.68 B

According to Halozyme Therapeutics's latest financial reports the company has S$0.68 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.44 B-8.76%
2022-12-31S$0.48 B-51.33%
2021-12-31S$0.99 B105.38%
2020-12-31S$0.48 B-14.11%
2019-12-31S$0.56 B17.29%
2018-12-31S$0.48 B-23.04%
2017-12-31S$0.62 B111.54%
2016-12-31S$0.29 B93.41%
2015-12-31S$0.15 B-14.4%
2014-12-31S$0.17 B97.77%
2013-12-31S$90.6 M-25.59%
2012-12-31S$0.12 B77.98%
2011-12-31S$68.41 M-36.24%
2010-12-31S$0.10 B13.17%
2009-12-31S$94.8 M3.48%
2008-12-31S$91.62 M-35.13%
2007-12-31S$0.14 B108.43%
2006-12-31S$67.76 M112.71%
2005-12-31S$31.85 M34.95%
2004-12-31S$23.6 M2654.08%
2003-12-31S$0.85 M407.92%
2002-12-31S$0.16 M248.88%
2001-12-31S$0.04 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.32 B-53.17%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.38 B 535.88%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.72 B 296.01%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.24 B 1,242.27%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.48 B 1,276.88%๐Ÿ‡ซ๐Ÿ‡ท France
S$33.18 B 4,715.42%๐Ÿ‡บ๐Ÿ‡ธ USA